We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
Cap. Flow
-$46M
Cap. Flow %
-9.03%
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$3.68M
2
RRGB icon
Red Robin
RRGB
+$3.46M
3
INTA icon
Intapp
INTA
+$3.34M
4
OI icon
O-I Glass
OI
+$3.16M
5
PDFS icon
PDF Solutions
PDFS
+$2.91M

Top Sells

Rank Stock Value
1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$4.8M
2
TH icon
Target Hospitality
TH
+$4.6M
3
PDSB icon
PDS Biotechnology
PDSB
+$4.36M
4
DGII icon
Digi International
DGII
+$4.3M
5
KLXE icon
KLX Energy Services
KLXE
+$4.07M

Sector Composition

Rank Sector Weight
1 Healthcare 25%
2 Technology 21.39%
3 Industrials 20.38%
4 Consumer Discretionary 11.68%
5 Energy 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMHI icon
351
SEACOR Marine Holdings
SMHI
$258M
– –
-124,721
Closed -$1.14M
SNDX icon
352
Syndax Pharmaceuticals
SNDX
$1.82B
– –
-35,391
Closed -$901K
SNEX icon
353
StoneX
SNEX
$7.94B
– –
-146,949
Closed -$2.77M
SPFI icon
354
South Plains Financial
SPFI
$841M
– –
-42,454
Closed -$1.17M
SPXC icon
355
SPX Corp
SPXC
$10.8B
– –
-36,921
Closed -$2.42M
SRCE icon
356
1st Source
SRCE
$2.12B
– –
-16,653
Closed -$884K
SRI icon
357
Stoneridge
SRI
$213M
– –
-50,384
Closed -$1.09M
SRPT icon
358
Sarepta Therapeutics
SRPT
$1.77B
– –
-8,491
Closed -$1.1M
SSBK
359
DELISTED
Southern States Bancshares
SSBK
– –
-54,223
Closed -$1.57M
STIM icon
360
Neuronetics
STIM
$166M
– –
-302,560
Closed -$2.08M
STR
361
DELISTED
Sitio Royalties
STR
– –
-46,103
Closed -$1.33M
SUPN icon
362
Supernus Pharmaceuticals
SUPN
$2.77B
– –
-66,030
Closed -$2.36M
SURG icon
363
SurgePays
SURG
$7.27M
– –
-238,959
Closed -$1.57M
TCBK icon
364
TriCo Bancshares
TCBK
$1.83B
– –
-18,221
Closed -$929K
TH icon
365
Target Hospitality
TH
$1.64B
– –
-304,011
Closed -$4.6M
TITN icon
366
Titan Machinery
TITN
$445M
– –
-58,327
Closed -$2.32M
TRMD icon
367
TORM
TRMD
$3.02B
– –
-39,958
Closed -$1.17M
TSBK icon
368
Timberland Bancorp
TSBK
$351M
– –
-46,986
Closed -$1.6M
TUSK icon
369
Mammoth Energy Services
TUSK
$163M
– –
-244,508
Closed -$2.11M
UBSI icon
370
United Bankshares
UBSI
$6.62B
– –
-22,604
Closed -$915K
ULH icon
371
Universal Logistics Holdings
ULH
$529M
– –
-22,361
Closed -$748K
URBN icon
372
Urban Outfitters
URBN
$6.59B
– –
-86,339
Closed -$2.06M
VMI icon
373
Valmont Industries
VMI
$9.53B
– –
-5,356
Closed -$1.77M
ZYXI
374
DELISTED
Zynex
ZYXI
– –
-132,196
Closed -$1.84M
PSTX
375
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-218,305
Closed -$1.16M
12 13 14
15
16

Similar funds

RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return

EAM Investors's Q1 2023 Portfolio in Review

As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.

  • EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
  • EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
  • EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
  • EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
  • EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
  • EAM Investors opened 139 new positions and closed 144 in Q1 2023.
  • EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.

Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.